LMAT Stock Recent News
LMAT LATEST HEADLINES
LeMaitre Vascular, Inc. (NASDAQ:LMAT ) Q1 2024 Earnings Conference Call May 2, 2024 5:00 PM ET Company Participants J.J. Pellegrino - Chief Financial Officer George LeMaitre - Chief Executive Officer Dave Roberts - President Conference Call Participants Rick Wise - Stifel Suraj Kalia - Oppenheimer Daniel Stauder - Citizens JMP Michael Sarcone - Jefferies Brett Fishbin - KeyBanc Operator Good day ladies and gentlemen.
LeMaitre Vascular (LMAT) came out with quarterly earnings of $0.44 per share, beating the Zacks Consensus Estimate of $0.39 per share. This compares to earnings of $0.27 per share a year ago.
BURLINGTON, Mass., March 26, 2024 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that JJ Pellegrino, Chief Financial Officer, will present virtually at the 23rd Annual Needham Virtual Healthcare Conference on Wednesday, April 10, 2024, at 11:30 AM ET.
TOL, WILYY and LMAT made it to the Zacks Rank #1 (Strong Buy) momentum stocks list on March 7, 2023.
Does LeMaitre Vascular (LMAT) have what it takes to be a top stock pick for momentum investors? Let's find out.
LMAT, SPXC and BBVA made it to the Zacks Rank #1 (Strong Buy) momentum stocks list on March 5, 2023.
BURLINGTON, Mass., March 01, 2024 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that management will be participating in four upcoming investor conferences in March.
LeMaitre (LMAT) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
LeMaitre Vascular, Inc. (LMAT) Q4 2023 Earnings Call Transcript
Investors with an interest in Medical - Products stocks have likely encountered both Medtronic (MDT) and LeMaitre Vascular (LMAT). But which of these two stocks offers value investors a better bang for their buck right now?